GBPL's "Protein Antibacterial Technology Platform (PATP)" is based on its extensive knowledge of phage biology, naturally occurring antibacterial proteins and the ability to identify and model functional domains of putative antibacterial proteins using detailed bioinformatics. The proprietary bioinformatic platform and the standardized cascade of experiments allow rapid confirmation of antibacterial activity targeting different bacterial pathogens.
